sq-11725 has been researched along with glucagon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehgartner, GR; Zelinka, MA | 1 |
| Buchanan, KD; Dow, RJ; Isles, TE; Martin, BT; Peden, NR; Yee, KF | 1 |
| Bassett, AL; Gaide, MS; Gelband, H | 1 |
1 trial(s) available for sq-11725 and glucagon
| Article | Year |
|---|---|
The effect of chronic treatment with a non-selective beta-adrenoceptor antagonist on the enteroinsular axis and intermediary metabolites.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Alanine; Antihypertensive Agents; Blood Glucose; Clinical Trials as Topic; Double-Blind Method; Gastric Inhibitory Polypeptide; Glucagon; Humans; Hydroxybutyrates; Hypertension; Insulin; Kinetics; Lactates; Male; Middle Aged; Nadolol; Propanolamines; Pyruvates | 1985 |
2 other study(ies) available for sq-11725 and glucagon
| Article | Year |
|---|---|
Hemodynamic instability following intentional nadolol overdose.
Topics: Emergencies; Female; Fluid Therapy; Glucagon; Hemodynamics; Humans; Infusions, Intravenous; Middle Aged; Nadolol | 1988 |
Relaxation by glucagon of potassium contracture in cat ventricle.
Topics: Adrenergic beta-Antagonists; Animals; Cats; Glucagon; Myocardial Contraction; Nadolol; Potassium; Propanolamines | 1981 |